We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

InVivo Therapeutics Receives Approval for First Human Trial Using Biomaterials for Traumatic Spinal Cord Injury

News   Apr 10, 2013

 
InVivo Therapeutics Receives Approval for First Human Trial Using Biomaterials for Traumatic Spinal Cord Injury
 
 
 

RELATED ARTICLES

Zika Vaccine Clinical Trial Begins

News

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

READ MORE

HIV Therapy Reduces Virus and Boosts Immunity in Drug-Resistant Patients

News

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options.

READ MORE

Researchers Reverse Blindness

News

Researchers change Müller glia into rod photoreceptors in mice and reverse congenital blindness

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE